Clinical Nutrition Market Size By Product [Infant Nutrition (Milk, Soy, Organic), Parenteral Nutrition (Amino Acids, Fats, Carbohydrates), Enteral Nutrition (Standard Composition, Disease Specific Composition)], Regional Outlook (US, Canada, UK, Germany, France, Spain, Italy, Russia, Japan, China, India, Australia, Malaysia, Mexico Brazil, South Africa, UAE, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2017 – 2024
Published Date: April 2017 | 140 Pages | Report ID: GMI1324 Report Format: PDF
Clinical Nutrition Market size was valued at over USD 40 billion in 2015 and is expected to witness more than 7% CAGR till 2024.
Europe Clinical Nutrition Market, By Product, 2012 - 2024 (USD Million)
Rising geriatric population especially in industrialized economies is a primary factor stimulating market growth. Elderly population is likely to have major health concerns pertaining to metabolic disorders and loss of appetite. Metabolic syndrome affects around 35% U.S. adults and 50% of population above 60 years. Prescription trend of nutritional products to aged population will drive industry growth over the coming years.
Malnutrition and increased intake of junk foods are the most common factors driving clinical nutrition prescription sales in children. Poverty and lack of awareness results in number of deficiencies amongst children in the developing regions.
High birth rate coupled with increased healthcare awareness in emerging economies should stimulate clinical nutrition market growth. Rise in number of government initiatives for upgradation and sophistication of healthcare facilities should also fuel business growth. Increasing prevalence of metabolic diseases worldwide, growing trend for home healthcare and availability of advanced products should also fuel growth.
Stringent government regulations, lack of uniform reimbursement policies worldwide, market volatility and complexities in patient compliance are some of the factors hindering the market growth.
Clinical Nutrition Market, By Product
Infant products grabbed over 55% of industry share with over 9% CAGR. High birth rate in developing countries, growing number of pre-mature births, increasing baby boomer’s population coupled with surge in metabolic disorders should contribute towards clinical nutrition market expansion. Milk based products held more than 70% of infant market share owing to the rising preference for milk products among infant caretakers.
2015 parenteral clinical nutrition industry was valued over USD 4.2 billion and is expected to witness more than 5% CAGR. Increasing incidence of chronic diseases such as cancer, HIV/AIDS, and diabetes is the major factor stimulating the business growth. The industry will witness a shift from parenteral to enteral nutrition leading to a declining parenteral share over the forecast years. Amino acid based products held over 40% of parenteral nutrition market share while fat based products should witness the highest growth in parenteral business.
Enteral held around 30% of the market share. Patients generally prefer enteral form over other routes of food administration owing to its convenience of usage for longer duration. Technological advances in enteral feeding devices will further accelerate the enteral products.
Clinical Nutrition Market, By Region
U.S. clinical nutrition market size in 2015 was valued over USD 8 billion and is anticipated to witness more than 6% CAGR over the forecast years. Advanced healthcare infrastructure, rising geriatric population, surging chronic disease burden and favorable reimbursement scenario will drive business growth.
Germany held around 18% of regional revenue share witnessing a considerable growth. The factors driving industry growth are increasing chronic disease prevalence, rising patient disposable income levels, growing geriatric population and sophistication in healthcare infrastructure.
2015 China market was valued more than USD 6 billion and is expected to witness over 9% growth. Increasing population, high birth rate, rapid economic development, growing disease burden and improvement in healthcare system infrastructure should boost industry expansion.
Indian is expected to witness over 9% CAGR driving the regional industry growth. Growing incidence of malnutrition, increasing population, high birth rate, increasing disease burden and favorable government initiatives for providing better healthcare services should propel market growth.
Competitive Market Share
Global clinical nutrition market is dominated few players such as Abbott Laboratories, Danone, Fresenius Kabi, Nestle, B Braun Melsungen, Hospira, Perrigo, H. J. Heinz, Baxter International and Mead Johnson.
The industry witnesses a consumer preference for branded products with few international brands dominating the industry. The new market entrants should face fierce competition from the existing industry leaders, who holds the significant market share of the global industry revenue.
Clinical Nutrition Industry Background
Clinical Nutrition is primarily supposed to be administered to patients and includes management of patient’s diet both for in-patients (hospitalized patients) and out patients (clinics, home healthcare etc.). The primary aim is to provide sufficient protein, vitamins, minerals and other vital requirements to patients to maintain their body energy balance.
Demand is growing worldwide due to rising chronic disease burden, increasing aging population, growing number of premature births in emerging economies. Enteral will drive the clinical nutrition industry over the forecast years. The industry is highly competitive with very few players holding majority share.
What Information does this report contain?
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security